semaglutide solution | Peptide Synthetic | High Purity An Ongoing Crisis: Semaglutide Shortage

Retatrutide has published Phase 2 data (2023) and the 2024 Nature Medicine hepatic substudy, with Phase 3 TRIUMPH data beginning to emerge

Another study focusing on individuals taking a 2.4 mg dose of semaglutide found that those who experienced diarrhea only dealt with the symptoms for about three days

Another option to enhance the effectiveness of annual flu vaccines is to make them with broader protection against multiple variants

Clinical experience: Nasal glucagon (Baqsimi) is feasible for rescue indications, with bioavailability of approximately 30%40%, rapid onset suitable for hypoglycemia rescue, and needle-free administration important for caregivers treating unconscious patients ( Best fit: Very potent peptides requiring small doses, rescue medications where needle-free administration is valuable (hypoglycemia, opioid overdose), or CNS-targeted strategies where direct nose-to-brain access may offer advantages over systemic administration